Why choose DefiniGEN?

It is known that genetic variability in donors can influence the capacity of donor material to generate truly pluripotent lines that can effectively differentiate in to “end” cell types.

DefiniGEN projects are structured to ensure the client receives their desired custom patient-derived iPSC cell disease model by using multiple donors and clonal lines with the lines being assessed and ranked at each stage to ensure that the best line is used in large scale custom cell model production.